Author Question: How long does an officer of a publicly traded company have to file a disclosure of transactions in ... (Read 105 times)

hubes95

  • Hero Member
  • *****
  • Posts: 561
How long does an officer of a publicly traded company have to file a disclosure of transactions in the company's stock?
 A) Until the end of the month
 B) Two days
 C) Three days
 D) Until the end of the quarter

Question 2

Under Sarbanes-Oxley, who cannot be a member of an audit committee of a publicly traded company?
 A) Officer
 B) Consultant to the company
 C) Outside lawyer for the company
 D) All of the above cannot be a member of the company's audit committee



JCABRERA33

  • Sr. Member
  • ****
  • Posts: 344
Answer to Question 1

B

Answer to Question 2

D



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Alcohol acts as a diuretic. Eight ounces of water is needed to metabolize just 1 ounce of alcohol.

Did you know?

About one in five American adults and teenagers have had a genital herpes infection—and most of them don't know it. People with genital herpes have at least twice the risk of becoming infected with HIV if exposed to it than those people who do not have genital herpes.

Did you know?

Stevens-Johnson syndrome and Toxic Epidermal Necrolysis syndrome are life-threatening reactions that can result in death. Complications include permanent blindness, dry-eye syndrome, lung damage, photophobia, asthma, chronic obstructive pulmonary disease, permanent loss of nail beds, scarring of mucous membranes, arthritis, and chronic fatigue syndrome. Many patients' pores scar shut, causing them to retain heat.

Did you know?

Nearly 31 million adults in America have a total cholesterol level that is more than 240 mg per dL.

Did you know?

Chronic necrotizing aspergillosis has a slowly progressive process that, unlike invasive aspergillosis, does not spread to other organ systems or the blood vessels. It most often affects middle-aged and elderly individuals, spreading to surrounding tissue in the lungs. The disease often does not respond to conventionally successful treatments, and requires individualized therapies in order to keep it from becoming life-threatening.

For a complete list of videos, visit our video library